Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 485 DKK 1.57% Market Closed
Market Cap: 98.3B DKK
Have any thoughts about
Genmab A/S?
Write Note

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 2 378.34 DKK with a low forecast of 348.59 DKK and a high forecast of 3 118.5 DKK.

Lowest
Price Target
348.59 DKK
77% Downside
Average
Price Target
2 378.34 DKK
60% Upside
Highest
Price Target
3 118.5 DKK
110% Upside
Genmab A/S Competitors:
Price Targets
VITR
Vitrolife AB
27% Upside
DAWN
Day One Biopharmaceuticals Inc
200% Upside
4891
TMS Co Ltd
266% Upside
ARQT
Arcutis Biotherapeutics Inc
24% Upside
PTCT
PTC Therapeutics Inc
4% Upside
NVAX
Novavax Inc
107% Upside
002252
Shanghai RAAS Blood Products Co Ltd
4% Downside
DNLI
Denali Therapeutics Inc
110% Upside

Revenue
Forecast

Revenue Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 40%. The projected CAGR for the next 4 years is 19%.

40%
Past Growth
19%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 28%. The projected CAGR for the next 4 years is 24%.

28%
Past Growth
24%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 24%. The projected CAGR for the next 4 years is 26%.

24%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
2 378.34 DKK

According to Wall Street analysts, the average 1-year price target for GMAB is 2 378.34 DKK with a low forecast of 348.59 DKK and a high forecast of 3 118.5 DKK.

What is Genmab A/S's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 40%. The projected CAGR for the next 4 years is 19%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 28%. The projected CAGR for the next 4 years is 24%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 24%. The projected CAGR for the next 4 years is 26%.

Back to Top